Analyst Joseph Pantginis of H.C. Wainwright reiterated a Buy rating on Actinium Pharmaceuticals (ATNM – Research Report), retaining the ...

Actinium Pharmaceuticals is a fantastic biotech company with a promising solution for a subset of AML patients. See why ATNM ...

(RTTNews) - Actinium Pharmaceuticals Inc. (ATNM) said that median overall survival of 5.49 months observed in patients with a TP53 mutation receiving an Iomab-B led allogeneic bone marrow transplant ...

ATNM stock results show that Actinium Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024 ...

Actinium shares were up 15% in early afternoon trading while shares of Fusion shot up 20%. Actinium, Fusion and RayzeBio are ...

NYSEAM:ATNM) Actinium to Host KOL Webinar to Discuss Iomab-ACT Commercial CAR T-Cell Therapy Trial Design, Objectives and Potential Market Opportunity ...

Actinium Pharma – Pivotal Results From Key New Drug In The Fight Against Cancer Sandesh Seth, CEO & Chairman of the Board of Actinium Pharmaceuticals (NASDAQ: ATNM), was recently a guest on ...

Invest with your heart and your phone with as little as $1 with these ESG and socially responsible investing apps.

NEW YORK - Actinium Pharmaceuticals (NYSE:ATNM), Inc. (NYSE AMERICAN: ATNM), a biotechnology firm specializing in targeted radiotherapies, has announced significant results from its Phase 3 SIERRA ...

(RTTNews) - Actinium Pharmaceuticals Inc. (ATNM) said that median overall survival of 5.49 months observed in patients with a TP53 mutation receiving an Iomab-B led allogeneic bone marrow ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...